Ryman Healthcare (ASX:RYM): What Does the Eight-Quarter High in Resales Mean for FY27?

Aditi Sarkar

27 October 2026 10:33 PM AEDT

Ryman Healthcare (ASX:RYM): What Does the Eight-Quarter High in Resales Mean for FY27?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Ryman Healthcare (ASX:RYM) recorded 379 occupation right agreement sales in Q2 FY27.
Resales reached 312, rising 14% YoY and marking an eight-quarter high.
FY26 total revenue increased 12.5% YoY to NZD 855.6mn, while the statutory loss narrowed.
Q2 FY27 aged care occupancy was 94.0%, up 3.3 percentage points YoY.

Ryman Healthcare Limited (ASX:RYM) develops and operates retirement villages and aged care facilities across New Zealand and Australia. Its shares finished trading on 27 October 2026 at AUD 1.43. The company’s latest quarterly update reported an increase in retirement living resales and higher aged care occupancy, placing its sales conversion, available unit stock and cash release priorities in focus ahead of the next financial results.

Company Business

Ryman Healthcare Limited (ASX:RYM) operates integrated villages offering independent retirement living, serviced apartments and aged care within the same communities. The model combines occupation right agreement sales with care and village fees, deferred management fees and other resident-related revenue. Its activities span New Zealand and the Australian state of Victoria, where it operates retirement villages and aged care centres.

Recent Development

In its October 2026 trading update, Ryman Healthcare Limited (ASX:RYM) reported 379 occupation right agreement sales during the quarter ended 30 September 2026. These comprised 312 resales and 67 new sales. Resales rose 14% from the corresponding quarter, marking the highest quarterly resale volume in eight quarters. Net resale contracts increased 11% YoY, following a 7% increase in the preceding quarter.

New retirement living inventory fell by 67 units during Q2 FY27 to 347. Since 31 March 2026, the reduction totalled 132 units, reflecting sales and the absence of new stock completions in the first half. Ryman also reported that its Richard Hadlee Village main building opened in October, delivering 77 retirement living units and 65 care beds. The company retained FY27 build guidance of 157–168 units and beds.

Total aged care occupancy reached 94.0%, compared with 90.7% a year earlier. Mature-centre occupancy was 95.4%, slightly below 95.7% in Q2 FY26, while occupancy across five mature Victorian care centres reached 97.9%, up from 96.1%. Ryman also expanded its Resident Fund offering in New Zealand and continued introducing its Ryman Select serviced-apartment product.

Financial Performance and Sector Context

For the year ended 31 March 2026, Ryman Healthcare Limited (ASX:RYM) reported statutory revenue of NZD 855.6mn, versus NZD 760.7mn in the restated comparative period, representing 12.5% YoY growth. Its statutory net loss narrowed to NZD 171.3mn from NZD 513.7mn. The reported result included a NZD 104.3mn negative fair value movement in investment properties, illustrating how property valuations can affect statutory earnings.

Separately, the company reported FY26 operating revenue of approximately NZD 849mn, up 10%, and operating EBITDAF of NZD 88mn, up 94%. Free cash flow was positive NZD 188mn, aided by cash released from developments. Management reported gearing of 27.8% and said its bank facilities had no maturities until FY31 following refinancing. These are distinct accounting and operating measures and should not be interpreted interchangeably.

Risks to Consider

Ryman Healthcare Limited (ASX:RYM) faces exposure to slower residential property transactions, delays in occupation right agreement settlements and pressure on care operating costs. Development spending can absorb cash before completed accommodation is sold, while unsold stock affects capital efficiency. Regulatory requirements for aged care, workforce availability, financing costs and changes in investment-property valuations add further uncertainty. Progress in resales may also vary between independent units and serviced apartments.

What to Watch Next

Ryman Healthcare Limited (ASX:RYM) aims to match resales with unit turnover by the end of FY27. Upcoming disclosures will clarify progress on vacant inventory, the remaining FY27 construction programme and NZD 150mn–180mn capital expenditure guidance, alongside longer-term cash release targets.

Key Insights

Ryman Healthcare Limited (ASX:RYM) reported an eight-quarter high in resale activity and higher overall care occupancy in Q2 FY27. FY26 revenue rose and statutory losses narrowed, although investment-property valuation adjustments remained material. The balance between resale conversion, care earnings, development expenditure and inventory reduction will shape subsequent reported performance.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.